1) Bretschneider(HTK)
心脏停博液
2) Cardioplegia
心脏停搏液
1.
Objective: To investigate the protective effects of cardioplegia with sodium channel inhibitor tetrodotoxin(TTX) on ischemia/reperfusion models of isolated rat hearts and isolated cardiomyocytes so as to explore a new myocardial protective method.
目的: 研究河豚毒素(tetrodotoxin,TTX)心脏停搏液对离体大鼠缺血/再灌注心肌在器官水平和细胞水平的保护作用,探索新的心肌保护方法。
2.
Objective To investigate the protective effects and mechanisms of polarizing cardioplegia with sodium channel inhibitor tetrodotoxin (TTX) on isolated cardiomyocytes of rat.
目的 探讨Na+通道阻滞剂河豚毒素（tetrodotoxin,TTX）极化心脏停搏液对离体大鼠心肌细胞的保护作用及其机制。
3.
Aim:To investigate the effects of polarizing cardioplegia solution with sodiumchannel inhibitor tetrodotoxin(TTX)on intracellular free Na~+ concentration([Na~+]_i)in isolated cardiomyocytes of rat.
目的:观察Na~+通道阻滞剂河豚毒素(TTX)极化心脏停搏液对离体大鼠心肌细胞内游离Na~+浓度([Na~+]_i)的影响。
3) Cardioplegic solution
心脏停搏液
1.
Cold crystal cardioplegic solution was infused through ascending aorta at initial time,20 min after blood flow being blocked,the cardioplegic solution containing blood was infused every 20～30 min .
方法选择2005年12月～2006年12月体外循环下行冠状动脉旁路移植术患者60例,随机分为实验组和对照组各30例,对照组经升主动脉根部首剂灌注冷晶体高钾心脏停搏液,阻断主动脉后20min开始每隔20～30min灌注含血心脏停搏液;实验组则于含血心脏停搏液基础上加入参附注射液20mL/L。
2.
Objective: To evaluate the myocardial protective effects of HTK cardioplegic solution in the patients undergoing cardiac valve replacement, in comparison with St ?Thomas II cardioplegia and 4 : 1 cold blood cardioplegia.
目的：通过对比三种心脏停搏液在风湿性心脏病患者瓣膜置换术中心肌保护的效果，初步评价HTK停搏液的心肌保护作用。
3.
Effect of Penehyclidine Hydrochloride on Myocardium during Cardiopulmonary Bypass Heart Surgery【Objective】To observe the effect of penehyclidine hydrochloride on myocardium during cardiopulmonary bypass(CPB) heart surgery through cardioplegic solution.
【目的】观察在体外循环(CPB)心脏手术中,经心脏停搏液使用盐酸戊乙奎醚(长托宁)对心肌的影响。
4) cardioplegia
心脏停跳液
1.
Objective To probe the myocardial protection of FDP cardioplegia.
ThomasⅡ号停跳液 ) ,对手术中心脏停跳液用量、心脏停搏情况、心脏复跳情况、心脏复跳后ST段恢复至基线所需时间、术后心律失常的发生率、血中肌钙蛋白T(TnT)等指标进行了观察。
5) blood cardioplegia
含血心脏停搏液
6) Cardioplegia
心脏含血停搏液
1.
The purpose of this srudy is to observe the clinical effects of cardioplegia with adenosine in cardiopulmonary bypass.
目的 在心肺转流(cardiopulmonary bypass CPB)中采用心脏含血停搏液灌注是心肌保护的一个里程碑，但随着人口的老龄化，换瓣和冠脉搭桥患者增多尤其是高危患者增多，对心肌保护提出了进一步的要求。
2.
The Effect of Blood Cardioplegia With Exogenous Adenosine on Myocardial Protection in Patients Following Open Heart Surgery With Extracorporeal Circulation;
目的观察心脏含血停搏液加入外源性腺苷在心内直视术中的心肌保护作用。
补充资料：非心源性心脏骤停
非心源性心脏骤停
除心脏本身疾病以外的其他疾患或因素影响到心脏而导致的心脏骤停。常见的原因有：①电解质和酸碱平衡失调，尤其是严重的高钾血症和低钾血症。②药物中毒或过敏导致严重的心律失常，特别是心室颤动而致心脏骤停。③手术：治疗操作和麻醉意外，各种心导管检查等，由于机械性刺激，迷走神经过度兴奋、缺氧和二氧化碳潴留，麻醉药物作用及低温对心脏影响均可致心室颤动或心脏骤停。此外，电击、雷击、溺水等原因均可致心跳骤停。详见心脏骤停条目。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条